Clinical trial
Chemotherapy in Treating Patients With Advanced Sarcoma
NCT00002526 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00002526 |
|---|---|
| Title | Chemotherapy in Treating Patients With Advanced Sarcoma |
| Official title | Continuous 5 Days Infusion of High Dose Ifosfamide and Adriamycin in Patients With Advanced Sarcoma |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Sarcoma |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, doxorubicin hydrochloride, ifosfamide |
| Enrollment | 20 |
| Start date | Jan 1, 1993 |
| Primary completion | Sep 1, 1995 |
| Completion | Sep 1, 1995 |
| First posted | Mar 11, 2004 |
| Last update posted | May 15, 2012 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: